He Had Severe Headaches for Years. Then This Happened.
C60 EVO is conducting publishable clinical trials on the ESS60 molecule to validate its effects on severe headaches, systemic inflammation (hs-CRP), sleep, and skin aging, driven by strong anecdotal evidence.summaryClinical Trial Focus Areas: The company is launching four specific publishable trials: 1) Frequent and severe headaches, 2) hs-CRP (inflammatory marker for cardiovascular disease/cancer), 3) Formalized sleep study, and 4takeaway“When I started taking this product on a regular basis at the beginning of 2018, I went for 18 months without getting a single one of these headaches.”quote














